HDC expands partnership with clinical lab
This article was originally published in Clinica
Molecular diagnostics firm Health Discovery Corporation has expanded an existing partnership with DCL Medical Laboratories for the development and commercialisation of support vector machine (SVM)-based, computer-assisted diagnostic systems. The two companies previously agreed in May this year to develop a SVM-based CAD technology for cervical cancer. This has now expanded to include ovarian and endometrial cancers. The resulting technology from this new deal will be designed for use in web-based applications, allowing remote review, second opinions and collaborative pathologist interpretation. HDC (Savannah, Georgia) will own the intellectual property of the developed products, while DCL will have a sole-use license for the applications and mathematical tools developed under the agreement. Financials details of the partnership were not revealed.